About

OncoScope-AI was formed by a group of scientists and software engineers with a proven record in oncology research, systematic reviews, and machine-learning platforms.

Leadership

Strategic partnership with Eviviz​

Strategic partnership with Pitts.ai

Selective publications by OncoScope-AI leadership

  • Forsythe A, Hearnden J, Dudoit K, Crotty C, Tremblay G. Real-time systematic literature reviews (SLR) – Dream or reality with computer-assisted methods: A case study in acute myeloid leukemia (AML). Value in Health 2019 May 01;22(Suppl 2):S102/PCN243
  • Hearnden J, Dudoit K, Kim E, Tremblay G, Forsythe A. Use of computer-assisted methods to realize the concept of a living systematic review via an online platform. Value in Health 2019 November 01;22(Suppl 3):S729/PMU118
  • Richard ME, Harricharan S, Forsythe A. Always up-to-Date Systematic Literature Reviews (SLRS Now a Reality – an Example in NEWLY Diagnosed Acute Myeloid Leukemia (ND AML) and Relapsed/Refractory Acute Lymphoblastic Leukemia (RR ALL). Value in Health 2020 December 01;23(Suppl 2):S473/PCN291
  • Moreau A, Richard ME, Harricharan S, Forsythe A. POSC422 The Impact of Congress Abstracts on Overall Publications in Acute Myeloid Leukemia (AML): Results of a Systematic Literature Review. Value in Health 2022 January; 25(1): S276
  • Moreau A, Richard ME, Harricharan S, Forsythe A. POSC421 Understanding the Impact of Congress Abstracts on Overall Publications in Multiple Myeloma (MM) – Results of a Systematic Literature Review (SLR). Value in Health 2022 January. 25(1): S275-276
  • He C, Ammann E, Forsythe A. CO141 Using LiveSLR platform to evaluate the impact of Duration of Treatment (DOT) on Progression Free Survival (PFS) in Multiple Myeloma (MM). Value in Health. 2022 December. Presented at ISPOR Europe November 2022, Austria, Vienna.
  • Liu RJ, Jafar R, Girard LA, Thorlund K, Forsythe A. MSR74 Can Artificial Intelligence (AI) Replace a Human Reviewer in Systematic Literature Review (SLR)? Validation of LiveSTART Tool. Value in Health. 2022 December. Presented at ISPOR Europe November 2022, Austria, Vienna.
  • Egunsola O, Verhoek A, Liu R, Thorlund K, Heeg B, Kwon C, Forsythe A. HTA145 Living Network Meta-Analysis for Up-to-Date Comparative Effectiveness: A Case Study in Multiple Myeloma Maintenance. Value in Health. 2022 December. Presented at ISPOR Europe November 2022, Austria, Vienna.
  • He C, Chen Z, Kwon C, Musat M, Liu R, Sarri G, Forsythe A. HTA199 The Reality of Living Systematic Literature Reviews (SLRs) to Support Timely Healthcare Decisions: A Case Study in Relapsed/Refractory Multiple Myeloma (RRMM). Value in Health. 2022 December. Presented at ISPOR Europe November 2022, Austria, Vienna.
  • Liu RJ, Verhoek A, Thorlund K, Heeg B, Sarri G, Forsythe A. HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM). Value in Health. 2022 December. Presented at ISPOR Europe November 2022, Austria, Vienna.
  • Liu J., Buer A., Rizzo M., Sarri G., Forsythe A. HTA63 The Data Lifecycle: Towards a Standardized Relational Data Model to Support Living Systematic Literature Reviews? – Use Case Demonstration with LiveSLR
  • Liu J., Jafar R., Girard L.A., Thorlund K., Forsythe A.MSR33 Re-Training of the Artificial Intelligence (AI) Tool LIVESTARTTM with Additional Datasets: Updated Accuracy in the Title and Abstract Review Stage of Systematic Literature Reviews (SLR). https://doi.org/10.1016/j.jval.2023.03.1569. Presented at ISPOR US 2023. Boston, USA
  • Liu J., Jafar R., Girard L.A., Thorlund K., Forsythe A.MSR8 Update on the LIVESTARTTM Artificial Intelligence (AI) Systematic Literature Review (SLR) Tool – Can It Aid in Limited Data Extraction for LIVEREFTM? https://doi.org/10.1016/j.jval.2023.03.1544. Presented at ISPOR US
  • Liu R., Mosselman J.J., Hanegraaf P., van der Schans J., Rizzo M., Forsythe A.Can an Integrated Systematic Literature Review (SLR) Database Improve the Speed of Title and Abstract (TIAB) Review? A Case Study Using Multiple Myeloma (MM) Projects in Interventional and Real-World Evidence (RWE) Evidence. Presented at ISPOR EU 2023.https://dx.doi.org/10.1016/j.jval.2023.09.2933